Tuyen Ong
CEO at Ring Therapeutics
Cambridge, Massachusetts
Overview
Work Experience
Chief Executive Officer
2020 - Current
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Raised $253,500,000.00 from Altitude Life Science Ventures, Flagship Pioneering, UPMC Enterprises, CJ Investment, Partners Investment, T. Rowe Price, Alexandria Venture Investments, Invus and Kyowa Kirin.
CEO partner
2020
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Member Board of Directors
2022
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Raised $100,000,000.00 from Forbion Capital Partners, Longwood Fund, Omega Funds and Atlas Venture.
Board of Advisors
2017
Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space.
Raised $135,000,000.00 from Novaquest Capital Management.
Board of Directors
2020 - 2022
SVP, Head of Ophthalmology Franchise
2019 - 2020
Biogen is a biotechnology company engaged in the development of innovative therapies for neurological and neurodegenerative diseases.
EVP, Chief Development Officer
2017 - 2019
Nightstar Therapeutics (Acquired by Biogen in June 2019)
Chief Medical Officer
2014 - 2017
SVP, Head of Clinical and Research Development (2014-2016)
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.
Raised $1,568,049,151.00 from Blackstone Life Sciences and Blackstone Credit.
VP, Clinical Development and Operations
2010 - 2014
Executive Director, Head of Clinical and Scientific Affairs (2010 -2013)
Bausch & Lomb is an eye health company bringing visionary Ideas to Eye Health.
Raised $1,400,000,000.00 from JP Morgan.
Global Clinical Lead
2005 - 2010
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.